Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Pharmacology. Jun 9, 2017; 6(2): 11-13
Published online Jun 9, 2017. doi: 10.5497/wjp.v6.i2.11
Published online Jun 9, 2017. doi: 10.5497/wjp.v6.i2.11
Tenofovir induced severe thrombocytopenia
Mayank Jain, Joy Vargese, Jayanthi Venkatatraman, Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Chennai 600100, India
Author contributions: All authors contributed to the acquisition of data, writing, and revision of this manuscript.
Institutional review board statement: As per institutional policy, we are not required to take Ethical Committee clearance for case reports.
Informed consent statement: As the patient has already given consent for reporting (attached), ethical clearance is not needed. No reports/images disclosing the patient identity have been used in the submission.
Conflict-of-interest statement: The authors do not report any conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Mayank Jain, Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Perumbakkam, Chennai 600100, India. mayank4670@rediffmail.com
Telephone: +91-44-24242424 Fax: +91-44-22777100
Received: February 13, 2017
Peer-review started: February 15, 2017
First decision: March 7, 2017
Revised: March 15, 2017
Accepted: April 16, 2017
Article in press: April 17, 2017
Published online: June 9, 2017
Processing time: 102 Days and 7.4 Hours
Peer-review started: February 15, 2017
First decision: March 7, 2017
Revised: March 15, 2017
Accepted: April 16, 2017
Article in press: April 17, 2017
Published online: June 9, 2017
Processing time: 102 Days and 7.4 Hours
Core Tip
Core tip: The present case report highlights a rare side effect of tenofovir therapy for hepatitis B infection. As the drug is commonly used in for management of hepatitis B and human immunodeficiency virus infection, the knowledge to this rare side effect would help physicians to be more watchful and improve patient management.